E-course: Spot on: Innovations in NMIBC follow-up – urine markers in clinical practice
This e-course will explore how recent advances in urine marker technology are transforming the management and monitoring of non-muscle-invasive bladder cancer (NMIBC) care. We will set the scene with a short introduction into the status of bladder cancer in Europe and the integration of urinary markers. We will explore how these innovations affect nursing practice and patient pathways, and a patient advocate will share perspectives on how urine markers can reduce the burden and anxiety.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | 1.00 |
| Duration | Approx. 60 minutes |
Learning objectives:
- Understand current innovations in NMIBC follow-up using urine markers.
- Describe how implementation of urine markers changes clinical and nursing pathways.
- Identify practical considerations for incorporating urine marker use into multidisciplinary bladder cancer care.
- Appreciate the patient perspective within this changing environment
Speakers:
- Dr. B.T. Jensen (DK)
- Ms. K. Chatterton (GB)
- Prof. Dr. T. Ecke (DE)
- Dr. T. Karmark Dreyer (DK)
- Mrs. L. Funk-Cirefice (BE)
- Mrs. R.N. Knudsen (DK)